National Cancer Institute, Acquisition Management Branch, TBS, 6120 Executive Blvd, EPS/Rm 603 Bethesda, MD 20892-7220

A -- BROAD AGENCY ANNOUNCEMENT FOR NOVEL TECHNOLOGIES FOR NONINVASIVE DETECTION, DIAGNOSIS AND TREATMENT OF CANCER SOL N01-CO-07013-32 DUE 030300 POC Richard L. Hartmann, Contracting Officer 301/496-8620 WEB: Complete copy of BAA N01-CO-07013-32, http://amb.nci.nih.gov/rfp/07013/07013.htm. E-MAIL: Richard L. Hartmann, Rich_Hartmann@nih.gov. The Unconventional Innovations Program (UIP) of the National Cancer Institute (NCI) is seeking revolutionary technologies for cancer research. The UIP is soliciting proposals for the development of multifunctional technology platforms to support minimally intrusive approaches that integrate: a) sensing of the fundamental signatures of precancers, or early, metastatic, or recurring cancers in the living body, b)transmission of signature information to an external monitor, c) controlled, specific, treatment, d) monitoring of the effects of treatment. The UIP particularly seeks technology platforms that integrate novel approaches to signature recognition, signal generation, signal amplification, signal transmission, intervention delivery, intervention feedback, and data interpretation. Proposals are encouraged from investigators from a variety of disciplines including, but not limited to, biomedical research, chemistry, physics, engineering, and computational sciences; particularly as multidisciplinary teams. The detailed Broad Agency Announcement is available on the web site of the Research Contracts and Acquisition Branch, NCI at: http://amb.nci.nih.gov/rfp/07013/07013.htm with instructions for submission of proposals and evaluation criteria. Posted 12/03/99 (W-SN405444). (0337)

Loren Data Corp. http://www.ld.com (SYN# 0005 19991207\A-0005.SOL)